Artur Faria: Oxygea

Artur Faria is CEO of Oxygea, a new CVC arm of Brazil-based Braskem, which was just announced last month.

Like a growing number of CVCs, Oxygea combines venture investment with venture-building activities (also known as CVB), the latter for which the unit plans to have 10 companies in its accelerator programme at any given time.

With Oxygea’s focus trained on sustainability and the digital transformation, Faria speaks about how capital will be allocated across its various functions and how Braskem has already rolled over several companies into its CVB portfolio.

He also talks through the inception of Oxygea and the rationale behind it, how he sees innovation progressing in Latin America and how corporates should walk their innovation talk.

Be sure to like, share and subscribe to the GVR podcast.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

Dr. Samuel West: Museum of Failure

Dr. Samuel West is a licensed clinical psychologist and specialist on organisational psychology, who is also the creator and curator of the Museum of Failure, a travelling collection of products that have failed in the conventional sense, but represent something far more important, which is the willingness to fail.

Anyone working in corporate innovation, corporate venture capital, or in any field of innovation will know that the fear of failure, the unwillingness to fail, effectively means the death of innovation. Without the appetite for risk, without the understanding that not every initiative will be successful, you’re left with an incredibly narrow path to creating anything new.

So what lessons can we draw from our own failures and those of others? Dr. West talks about the differences between good and bad failures, how organisations are not that different from individuals in terms of how they view and deal with failures, the importance of creating a psychologically safe environment where failure is not punished, and how he went about putting this impressive collection of corporate relics together.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

Rodrigo Gruner: Vivo

Rodrigo Gruner is director of innovation and new business at Vivo, the Brazilian subsidiary of telecoms company Telefónica, which earlier this year launched its own CVC unit, Vivo Ventures.

On this episode of GVR, Gruner speaks about where Vivo Ventures fits within Telefónica’s venturing ecosystem alongside other units like Wayra and Telefónica Ventures, and how its investment focus across areas like finance, healthcare, entertainment and education bring value to its core telco platform, even if the CVC itself leaves aside the “pure” telco plays.

He also talks about a host of other topics such as Vivo Ventures’ first-ever investment in open finance platform Klavi, the regional features in Latin America – such as an under-penetration of financial products like credit cards – that are driving growth in the CVC’s focus areas, as well as how Latin American corporates are advancing in their innovation journeys.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

Bill Reichert: Pegasus Tech Ventures

Bill Reichert is partner at Pegasus Tech Ventures, a VC as a service firm that makes venture investments on behalf of corporations. This is a model that has been on an upwards trajectory in recent years, as different corporates find themselves at different stages along their innovation journey and sometimes they need outside help, so they reach out to firms like Pegasus and others to help them navigate the venture capital ecosystem.

Reichert talks about the VCaaS model, its advantages and why some corporates choose to go that route as opposed to building their own units, and why the model is gaining so much popularity. He also talks at length about the history of corporate venture capital and how CVC as a service is the latest iteration of it – calling it CVC 4.0. Corporations, Reichert says, recognise that they need to innovate in order to survive, and just because a corporate might already have a CVC doesn’t mean that they don’t partner with firms like Pegasus anyway.

With a multi-sector array of partners, Reichert explains the challenges involved in formulating a strategy for each of them based on their individual needs, and how sometimes they need a lot of help getting the prerequisite groundwork and culture of innovation in place to enter the venture pool.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

Can record investment in agtech fix global food insecurity?

We are joined once again by GCV’s very own Kim Moore, who has recently written an article exploring a hugely important topic, food insecurity, a topic which has been aggravated by recent events such as Russia’s invasion of Ukraine, itself building on top of already longer-running themes like climate change and covid-related global supply chain shocks.

However, we’ve also seen a massive increase in venture capital flowing into agriculture technology round the world, which has massive potential to alleviate food shortages and maximise productivity and access to enabling services like financial technology across the industry.

Can record investment in agtech fix global food insecurity?


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

What background should CVC hires have?

The economy may be cold but CVC teams are growing and hiring. But what should you look for in candidates? What traits and attributes are best for new hires coming into a CVC?

Fernando discusses a recent GCV article on the topic with senior editor Maija Palmer.

Read the full article on the Global Venturing website.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

Gustavo Cavenaghi: Kortex Ventures

Gustavo Cavenaghi is the head of investments at Kortex Ventures – a CVC unit jointly backed by no less than three corporate limited partners, namely diagnostics technology providers Fleury and Sabin, as well as health insurance company Bradesco Saude.

Being a CVC for a single corporate is hard enough – but what about three of them? How do you juggle that? According to Cavenaghi, it’s a complex challenge with a simple answer, stick to your thesis and take an agnostic view.

In this episode, He also talks about the scale of the impact that the pandemic has had on the healthtech investment landscape, particularly in how it has supercharged demand for digital and telehealth services.

He also discusses how important genomics will become in the future of healthcare, the value of patience when trying to set up a new CVC and how corporates would do well to let their CVCs fly and do their own thing – though without breaking the corporate umbilical cord.

Don’t forget to like, share and subscribe to the show!


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

A growing corporate appetite for nuclear fusion

GCV’s very own Kim Moore joined the podcast to speak about her new feature article on nuclear fusion, exploring the advances that have made it more technologically and commercially viable, how it compares to existing nuclear energy technology, the current landscape of corporate investment supporting it, and where it fits into the clean energy matrix and our global context.

You can read Kim’s full article on our website.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

Anand Kamannavar: Applied Ventures

Technology can only get as advanced as the materials that make it up, and things are moving fast.

Anand Kamannavar is the global head of Applied Ventures, the CVC unit of advanced materials engineering company Applied Materials, investing in a wide range of technologies including energy, advanced materials and manufacturing, semiconductors, life sciences, AI and big data and more.

In this episode, he touches on the challenges involved with managing a considerable global portfolio when the whole team is based in California, how Applied Ventures seeks to enable the pushing of the envelope on Moore’s Law – the principle essentially stating that semiconductors double in complexity every few years – and how having been in the game for so long has helped the unit see ahead of the curve.

He also talks about the benefits of having had a stable, long-term and supportive relationship with the parent company, how investing in public companies can be a good play for a CVC, and how the similarities between VCs and CVCs are much bigger than the differences, particularly with the smaller VCs that are more specialised.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

The evolving landscape of corporate impact investing

Global Corporate Venturing features editor Rob Lavine joins the pod to talk about the shifting models corporate VC’s are employing for their impact investment activities.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0